最新更新 :
19/11/2024
研究チーム - Hôpital Robert Debré, Service pharmacie   PDF  
フランス
病院
Hôpital Robert Debré, Service pharmacie
Paris
E-メール
引用文献   引用文献   (7)  
1
Development and validation of a new HPLC method for the analysis of a novel oral suspension formulation of 50 mg/mL ursodesoxycholic acid for newborns.
Hausherr A, Roessle C, Pinet E, Vasseur V, Abarou T, Benakouche S, Bourdon O, Storme T. (olivier.bourdon@aphp.fr)
Pharmaceutical Technology in Hospital Pharmacy - 2020 -
2
Formulation of a 3-months Stability Oral Viscous Budesonide Gel and Development of an Indicating Stability HPLC Method.
Bonnet M, Dermu M, Roessle C, Bellaiche M, Abarou T, Vasseur V, Benakouche S, Storme T. (mathildb@hotmail.fr)
Pharmaceutical Technology in Hospital Pharmacy - 2018 -
3
Diluted solution of sodium ioxitalamate in paediatrics: A stability and cost effectiveness study.
Arrault XL, Rieutord A, Hassan M, Brion F. ()
EJHP - 2003 - ; 3: 34-42.
4
Stability and sterility of meglumine gadoterate injection repackaged in plastic syringes.
Micard S, Rieutord A, Prognon P, Hassan M, Brion F. ()
Int J Pharm - 2001 - ; 212: 93-99.
5
Stability and compatibility of an aerosol mixture including N-acetylcysteine, netilmicin and betamethasone
Rieutord A, Arnaud P, Dauphin JF, Brion F. ()
Int J Pharm - 1999 - ; 190, 1: 103-107.
6
Stability and compatibility study of a carboplatin solution in syringes for continuous ambulatory infusion.
Valière C, Arnaud P, Caroff E, Dauphin JF, Clément G, Brion F. ()
Int J Pharm - 1996 - ; 138: 125-128.
7
Stability and compatibility of 2.5 mg/ml methotrexate solution in plastic syringes over 7 days.
Jacolot A, Arnaud P, Lecompte D, Alamercery S, Caroff E, Naveau C, Guillot T, Bousselet M, Brion F. ()
Int J Pharm - 1996 - ; 128: 283-286.

薬剤一覧   研究分子   (9)  
抗炎症薬 エアロゾル Betamethasone sodium phosphate
抗炎症薬 経口液 Budesonide
細胞増殖抑制薬 注射薬 Carboplatin
放射線造影剤 注射薬 Gadoterate meglumine
放射線造影剤 注射薬 Ioxitalamate sodium
細胞増殖抑制薬 注射薬 Methotrexate sodium
様々なもの エアロゾル N-acetylcysteine
抗菌薬 エアロゾル Netilmicin sulfate
様々なもの 経口液 Ursodesoxycholique acid

  Mentions Légales